EUVIMEDEUVIMED entdecken
Crossref

A Framework of National Pharmacovigilance System for Developing Countries

Maryam Nikookalam, Hosseini Azamossadat, Hamid Moghaddasi, Farkhondeh Asadi, Afshin Zarghi

Iranian journal of pharmaceutical sciences · 01.04.2024

DOI: 10.22037/ijps.v20i2.44899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian journal of pharmaceutical sciences, erschienen am 01.04.2024. Verfasst von Maryam Nikookalam und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacovigilance is defined as “the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions or any other drug-related problems”. The framework of the national pharmacovigilance system illustrates the general pattern of how the health system approaches the care of health products, defines the philosophy of supervision and policy orientation, and outlines the structure and development priorities of pharmacovigilance. The present study was conducted with the aim of presenting a framework of the national pharmacovigilance system framework for developing countries. The present study is of an applied study that was conducted descriptively in 2023. To present a framework of the national pharmacovigilance system framework, the main components of the national pharmacovigilance system framework were first identified and determined through a review of valid scientific sources and texts and national pharmacovigilance systems of the countries under study, considering the conditions and requirements of these countries. Then, the proposed model was put to the opinion of 65 experts for validation, and the Delphi method was implemented with a three-point scale in two rounds. Based on the results of the present study, the main components of the national pharmacovigilance system framework include: functions, infrastructure, and network. Each component includes sub-components and related operations and was agreed upon by experts with an average agreement rate of 95%. The framework of the national pharmacovigilance system is essential as a guide for the implementation of the national pharmacovigilance system. This framework enables a comprehensive evaluation of the structures and national and regional institutions affecting pharmacovigilance and can lead to the optimal implementation of the national pharmacovigilance system in developing countries. The national pharmacovigilance system can reduce drug-related problems, and its ultimate result can be a reduction in mortality and morbidity rates.

Schlagwörter

adverse drug reactionsdrug-related problemsdeveloping countriesexpert consensusDelphi method

Zitieren

APA

Nikookalam, M., Azamossadat, H., Moghaddasi, H., Asadi, F., & Zarghi, A. (2024). A Framework of National Pharmacovigilance System for Developing Countries. Iranian journal of pharmaceutical sciences. https://doi.org/10.22037/ijps.v20i2.44899

Vancouver

Nikookalam M, Azamossadat H, Moghaddasi H, Asadi F, Zarghi A. A Framework of National Pharmacovigilance System for Developing Countries. Iranian journal of pharmaceutical sciences. 2024. doi:10.22037/ijps.v20i2.44899

BibTeX
@article{Nikookalam2024,
  author = {Nikookalam, Maryam and Azamossadat, Hosseini and Moghaddasi, Hamid and Asadi, Farkhondeh and Zarghi, Afshin},
  title = {A Framework of National Pharmacovigilance System for Developing Countries},
  journal = {Iranian journal of pharmaceutical sciences},
  year = {2024},
  doi = {10.22037/ijps.v20i2.44899}
}
Kostenlos starten →